ID: ALA5093324

Max Phase: Preclinical

Molecular Formula: C40H71N11O14

Molecular Weight: 930.07

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(C)=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(N)=O

Standard InChI:  InChI=1S/C40H71N11O14/c1-11-19(6)30(39(64)45-24(33(42)58)14-28(41)56)50-37(62)27(16-52)48-36(61)25(12-17(2)3)46-35(60)26(13-18(4)5)47-40(65)32(22(9)54)49-29(57)15-43-38(63)31(21(8)53)51-34(59)20(7)44-23(10)55/h17-22,24-27,30-32,52-54H,11-16H2,1-10H3,(H2,41,56)(H2,42,58)(H,43,63)(H,44,55)(H,45,64)(H,46,60)(H,47,65)(H,48,61)(H,49,57)(H,50,62)(H,51,59)/t19-,20-,21+,22+,24-,25-,26-,27-,30-,31-,32-/m0/s1

Standard InChI Key:  MSKIZGRQXUUASB-YDTYMFDWSA-N

Associated Targets(Human)

Leukocyte elastase 8173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 930.07Molecular Weight (Monoisotopic): 929.5182AlogP: -5.73#Rotatable Bonds: 29
Polar Surface Area: 408.77Molecular Species: NEUTRALHBA: 14HBD: 14
#RO5 Violations: 3HBA (Lipinski): 25HBD (Lipinski): 16#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.33CX Basic pKa: CX LogP: -6.34CX LogD: -6.34
Aromatic Rings: 0Heavy Atoms: 65QED Weighted: 0.03Np Likeness Score: 0.00

References

1. Lior Y, Shtriker E, Kahremany S, Lewis EC, Gruzman A..  (2022)  Development of anti-inflammatory peptidomimetics based on the structure of human alpha1-antitrypsin.,  228  [PMID:34763945] [10.1016/j.ejmech.2021.113969]

Source